Remove tag public-interest
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

Both drugs come with a high price tag. This is a trade-off between the patentee and the public where the patentee gets temporary exclusivity in exchange for revealing this information, adds Contreras. This case has broader implications for pharma as an industry, which explains the interest from other businesses.

104
104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Things I Love About The MAD-ID Conference, The Antimicrobial Stewardship Meeting

ID Stewardship

It has claimed the tag line “The Antimicrobial Stewardship Meeting.” There are a lot of good projects that are presented at MAD-ID and later emerge as meaningful peer reviewed publications. Every time I see her name on a paper I know it will be interesting to me. I have been following her work for many years.

article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

3 As a matter of public health, the more patients understand what medicines they take, and why, outcomes will improve. Marshall is a board-certified emergency medicine physician interested in trauma, improving efficiency and flow, and wellness in the community and healthcare settings. Joseph Guglielmo, PharmD. Dean, Troy C.

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

Despite this, pharmaceutical companies have not won over public trust. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. A recent study found that only 48% of participants expressed trust in pharmaceutical companies.

article thumbnail

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

The Physician Pharmacist

One of the most interesting parts of the podcast is when Dr. Brohol discusses his journey from pharmacy to medicine. He explains that he always had an interest in medicine, but didn't want to dedicate that much time to studying. Speaker 2 So to be honest, I always had an interest in medicine.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . The company has many interesting drugs in its pipeline, including a CAR-T therapy developed in partnership with Legend Biotech.

Vaccines 126